Irinotecan pharmacogenetics: a finished puzzle?
- PMID: 24958823
- DOI: 10.1200/JCO.2014.56.3387
Irinotecan pharmacogenetics: a finished puzzle?
Comment on
-
Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer.J Clin Oncol. 2014 Aug 1;32(22):2328-34. doi: 10.1200/JCO.2014.55.2307. Epub 2014 Jun 23. J Clin Oncol. 2014. PMID: 24958824 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
